Carina Wattmo
31 – 40 of 88
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2016
-
Mark
Short-term response to cholinesterase inhibitors in Alzheimer’s disease delays time to nursing home placement.
(2016) 14th International Athens/Springfield Symposium on Advances in Alzheimer Therapy In Neurobiology of Aging 39(Suppl. 1). p.2-2
- Contribution to journal › Published meeting abstract
-
Mark
Cholinesterase inhibitors do not alter the length of stay in nursing homes among patients with Alzheimer's disease : A prospective, observational study of factors affecting survival time from admission to death.
- Contribution to journal › Article
-
Mark
Prevalence of Dementia With Lewy Body Symptoms : A Cross-Sectional Study in 40 Swedish Nursing Homes
- Contribution to journal › Article
-
Mark
Cholinesterase inhibitor therapy does not affect time spent in nursing homes in patients with Alzheimer’s disease.
(2016) Alzheimer’s Association International Conference 2016
- Contribution to conference › Poster
-
Mark
Early- versus Late-Onset Alzheimer’s Disease—Differences in Functional Impairment.
(2016) 9th Clinical Trials Conference on Alzheimer’s Disease
- Contribution to conference › Poster
- 2015
-
Mark
Mild cognitive impairment and deficits in instrumental activities of daily living: a systematic review.
- Contribution to journal › Scientific review
-
Mark
Lack of orthostatic symptoms in dementia patients with orthostatic hypotension.
- Contribution to journal › Article
-
Mark
Longitudinal Associations between Survival in Alzheimer's Disease and Cholinesterase Inhibitor Use, Progression, and Community-Based Services.
- Contribution to journal › Article
-
Mark
Various measures of progression predicting mortality in Alzheimer’s disease.
(2015) Alzheimer’s Association International Conference (AAIC), 2015 In Alzheimer's & Dementia 11(7 Suppl.). p.293-294
- Contribution to journal › Published meeting abstract
-
Mark
Various outcomes of cholinesterase inhibitor treatment influence survival of patients with Alzheimer’s disease.
(2015) 12th International Conference on Alzheimer`s and Parkinson`s Diseases (AD/PD 2015)
- Contribution to conference › Poster
